Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 933-947
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.933
Table 3 Clinicopathological features by sex and histologic type
CharacteristicsIntestinal type
Diffuse type
Female (n = 447)
Male (n = 1396)
P value
Female (n = 494)
Male (n = 520)
P value
Age (yr, mean ± SD)65.72 ± 10.7164.06 ± 10.340.79253.60 ± 13.0655.82 ± 12.480.229
Drinking history, n (%)
No385 (86.1)619 (44.3)< 0.001a374 (75.7)183 (35.2)< 0.001a
Yes62 (13.9)777 (55.7)120 (24.3)337 (64.8)
Smoking history, n (%)
No420 (94.0)530 (38.0)< 0.001a447 (90.5)175 (33.7)< 0.001a
Yes27 (6.0)866 (62.0)47 (9.5)345 (66.3)
Family history, n (%)
No348 (77.9)1138 (81.5)0.088419 (84.8)447 (86.0)0.606
Yes99 (22.1)258 (18.5)75 (15.2)73 (14.0)
Tumor location, n (%)
Upper12 (2.7)44 (3.2)0.0537 (1.4)10 (1.9)< 0.001a
Middle139 (31.1)517 (37.0)334 (67.6)284 (54.6)
Lower296 (66.2)835 (59.8)153 (31.0)226 (43.5)
Atrophic gastritis, n (%)
No320 (71.6)951 (68.1)0.168400 (81.0)389 (74.8)0.018a
Yes127 (28.4)445 (31.9)94 (19.0)131 (25.2)
Intestinal metaplasia, n (%)
No229 (51.2)751 (53.8)0.344303 (61.3)306 (58.8)0.418
Yes218 (48.8)645 (46.2)191 (38.7)214 (41.2)
T stage, n (%)
T1355 (79.4)1087 (77.9)0.529314 (63.6)305 (58.6)0.445
T240 (9.0)138 (9.9)57 (11.5)66 (12.7)
T340 (9.0)145 (10.4)99 (20.0)118 (22.7)
T412 (2.6)26 (1.8)24 (4.9)31 (6.0)
N stage, n (%)
N0356 (79.6)1140 (81.7)0.745319 (64.6)335 (64.4)0.055
N156 (12.5)149 (10.7)97 (19.6)85 (16.4)
N220 (4.5)62 (4.4)42 (8.5)38 (7.3)
N315 (3.4)45 (3.2)36 (7.3)62 (11.9)
Stage, n (%)
I375 (83.9)1171 (83.9)0.49342 (69.2)347 (66.7)0.152
II47 (10.5)142 (10.2)96 (19.5)89 (17.1)
III23 (5.1)65 (4.6)43 (8.7)66 (12.7)
IV2 (0.5)18 (1.3)13 (2.6)18 (3.5)
Cancer type, n (%)
EGC355 (79.4)1086 (77.8)0.469314 (63.6)305 (58.7)0.109
AGC92 (20.6)310 (22.2)180 (36.4)215 (41.3)
P53, n (%)
Negative293 (65.5)770 (55.2)< 0.001a385 (77.9)393 (75.6)0.374
Positive154 (34.5)626 (44.8)109 (22.1)127 (24.4)